Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...

Highlights Promise of DNAbilize® Platform to Produce New Drug Candidates and Potential Licensing Opportunities HOUSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a ...

Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2025 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments ...

Hybrid immunity, through vaccines and exposure to the virus, is likely to protect people but they still need to follow Covid ...

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that its ColoSense® test has been included in the ...

The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...

Moody’s Ratings has downgraded the ratings of Maravai Intermediate Holdings, LLC, including the corporate family rating (CFR) to B3 from B2 and probability of default rating (PDR) to B3-PD from B2-PD.

Akadeum Life Sciences, a pioneer in buoyancy-based cell separation technology, today announced the successful close of a $20 million+ financing round. The round was led by Michigan Capital Network, ...

The surface plasmon resonance market has gained significant attention in recent years due to its crucial role in biosensing, diagnostics, and drug discovery. Surface plasmon resonance (SPR) technology ...

Depth Analysis of Technology Advances, Market Dynamics, and Global Growth Projections. Explore Key Trends, Regional Insights, and Strategic Opportunities Shaping the Industry. Executive Summary & ...

Increasing demand for non-invasive biomarkers to catapult growth in the exosome diagnostic and therapeutic market. The market size is expected to increase from USD 88.56 million in 2024 to USD 211.6 ...